Skip to Content

Cytarabine liposomal Pregnancy and Breastfeeding Warnings

Cytarabine liposomal is also known as: DepoCyt

Cytarabine liposomal Pregnancy Warnings

Cytarabine liposomal has been assigned to pregnancy category D by the FDA. Animal studies of cytarabine have revealed evidence of teratogenicity and embryotoxicity. There are no controlled data in human pregnancy. Following the intravenous administration of cytarabine (the active component of cytarabine liposomal), three anecdotal cases of major limb malformations have been reported. However, the manufacturer of cytarabine liposomal has stated that the concern for fetal harm following intrathecal cytarabine liposomal is low because systemic exposure to cytarabine is negligible. Cytarabine liposomal should only be given during pregnancy when there are no alternatives and benefit outweighs risk.

See references

Cytarabine liposomal Breastfeeding Warnings

There are no data on the excretion of cytarabine liposomal into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, the use of cytarabine liposomal is not recommended in nursing women.

See references

References for pregnancy information

  1. "Product Information. DepoCyt (cytarabine liposomal)." Chiron Therapeutics, Emeryville, CA.

References for breastfeeding information

  1. "Product Information. DepoCyt (cytarabine liposomal)." Chiron Therapeutics, Emeryville, CA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.